Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Virus+Diseases%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Virus+Diseases%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Virus+Diseases%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (7.356)
1
A clinical study to compare brincidofovir with current care for adenovirus infection in children after a bone marrow transplant : An Open-label, Randomized, Multi-center, Parallel Group, Two-arm Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir versus Standard of Care for Treatment of Adenovirus Infections in High-risk Pediatric Allogeneic Hematopoietic Cell Transplant Recipients - AdAPT: Adenovirus after Allogeneic Pediatric Transplantation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety : High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety - HISTORY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A vaccine and a device used together to treat women with precancerous cells on the cervix caused by human papillomavirus (HPV). : A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR HPV-18 RELATED HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL) OF THE CERVIX - Randomized Evaluation of VGX-3100 and Electroporation for the treatment of Cervical dysplasia REVEAL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Long-Term Follow-up Study looking at the Virologic Response (checking a patient's blood to ensure that there is no detectable virus) and/or Viral Resistance (checking that the virus has not changed in anyway which might mean that treatment is no longer effective) of Subjects With Chronic Hepatitis C Who Have Been Previously Treated with MK-5172 in a Prior Clinical Trial : A Long-Term Follow-up Study to Evaluate the Durability of Virologic Response and/or Viral Risistance Patterns of Subjects with Chronic Hepatitis C Who Have Been Previously Treated with MK-5172 in a Prior Clinical Trial. - A Long Term Follow-up Study of Subjects previously treated with MK5172
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A clinical study (Phase III) to assess the Evaluate the Protective Efficacy and Safety of a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT), when compared against placebo in a randomised, double blind manner. : A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Protective Efficacy and Safety of a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Single Arm, Open-label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis : A Single Arm, Open-label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Randomized, double blind, safety, efficacy Doravirine/Islatravir in Treatment naïve : A Phase 3 Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir Once-Daily in HIV-1 Infected Treatment-Naïve Participants - Randomized, double blind, safety, efficacy Doravirine/Islatravir in Tx naïve
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A Clinical Trial to Test Different Doses of MK-5172 administered with Other Hepatitis C Virus Treatments : A Phase II Randomized, Dose Ranging, Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Different Doses of MK-5172 When Administered Concomitantly with Peginterferon alfa-2b and Ribavirin in Treatment Naïve Subjects with Chronic Hepatitis C Virus Infection - MK-5172 + PegRiba in GT1 TN Patients Pilot Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A study to evaluate how safe MVA.HTI and ChAdOx1.HTI vaccines with vesatolimod are in participants with early treated HIV-1 infection. : A Phase IIa, randomized, double-blind, placebo-controlled, study of HIV-1 Vaccines MVA.HTI and ChAdOx1.HTI with TLR7 agonist vesatolimod (GS-9620), in early treated HIV-1 infection
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Safety of tenofovir alafenamide (TAF) in patients who developed kidney toxicity while receiving tenofovir disoproxil fumarate (TDF) : Safety of tenofovir alafenamide (TAF) in patients with a history of tubulopathy on tenofovir disoproxil fumarate (TDF) - FANCONI-TAF (FANTA) study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[736]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
7.356
Aufsätze
7.356
E-Artikel
7.356
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
7.356
610
7.330
Study Type: Interventional
4.792
Recruitment Status: Not yet recruiting
2.608
Phase: Phase 3
2.018
Phase: Phase 2
1.932
Recruitment Status: Authorised-recruitment may ...
544
Phase: Phase 4
234
Phase: Phase 1
64
Medical Condition: Influenza A Infection MedDRA...
52
Medical Condition: COVID-19;Therapeutic area: D...
52
Medical Condition: Chronic Hepatitis B Virus In...
50
Medical Condition: Human Immunodeficiency Virus...
50
Medical Condition: The prevention of medically ...
48
Medical Condition: Chronic Hepatitis B MedDRA v...
48
Medical Condition: Chronic Hepatitis C Infectio...
42
Medical Condition: Human Immunodeficiency Virus...
40
Medical Condition: COVID-19 MedDRA version: 23....
38
Recruitment Status: Recruiting
36
Medical Condition: Respiratory Syncytial Virus ...
34
Medical Condition: HIV-1 infection MedDRA versi...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.348
2020-
4.008
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7.208
Englisch
108
Unbestimmt
18
Spanisch
10
Französisch
6
Italienisch
4
Deutsch
2
Finnisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...